secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT)
CIK:        0001335105
Form:       8-K
Filed at:   2025-07-21T23:59:59+00:00
Accession:  0001641172-25-020408
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Lixte appoints two new independent directors; CMO resigns effective July 31
---------------------------------------------------------------------------

- Board adds Jason Sawyer and Dr. Michael Holloway as independent directors, designated by Series B Preferred Stock holders.
- Dr. Stephen Forman and Dr. Yun Yen resign from Board, will serve on Scientific Advisory Committee.
- Mr. Sawyer named Chairman of Compensation Committee and member of Audit Committee.
- Chief Medical Officer Dr. Jan Schellens resigns effective July 31, 2025; consulting agreement terminated.
- Resignations not due to any disagreement with company operations, policies, or practices.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1335105/000164117225020408/0001641172-25-020408-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1335105/000164117225020408/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-020408

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer